Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks

Page 7 of 12

6. Merck & Co., Inc. (NYSE:MRK)

Number of Hedge Fund Holders In Q3 2024: 86

Merck & Co., Inc. (NYSE:MRK) is a global pharmaceutical giant that has led the specialty drug market through its KEYTRUDA cancer drug. KEYTRUDA is one of the most widely sold drugs in the world and is expected to cross $60 billion in sales by 2026. Building on the back of its strong cancer drug, Merck & Co., Inc. (NYSE:MRK) estimates that it can earn as much as $20 billion in revenue from new cancer and oncology medicines by the mid-2030s. The stock jumped by 2.3% in January after a Chinese firm announced that it would sell an Ireland-based vaccine facility to Merck & Co., Inc. (NYSE:MRK) following tough US laws. Cramer’s previous comments have appreciated the firm’s GARDASIL HPV drug, and here’s his latest take:

“Merck, which is down very badly. Even though they’ve got Keytruda and a drug that’s going to be very much life saving.”

Page 7 of 12